EDAP TMS S.A. (FOCL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EDAP TMS S.A. (FOCL) has a cash flow conversion efficiency ratio of 1.143x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.69 Million) by net assets ($-3.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FOCL company net worth for the company's overall valuation and market capitalisation.
EDAP TMS S.A. - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how EDAP TMS S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
EDAP TMS S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EDAP TMS S.A. ranked by their cash flow conversion efficiency. Explore FOCL operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BBMG Corporation
F:9BM
|
0.032x |
|
St.Shine Optical Co Ltd
TWO:1565
|
0.059x |
|
Chant Sincere Co Ltd
TW:6205
|
0.034x |
|
Mega Uranium Ltd.
TO:MGA
|
-0.005x |
|
Brazil Potash Corp.
NYSE:GRO
|
-0.027x |
|
Atp Ticari Bilgisayar Agi ve Elektrik Guc Kaynaklari Uretim Pazarlama ve Ticaret
IS:ATATP
|
-0.291x |
|
JIUMAOJIU INTL HLDGS LTD
F:3YU
|
N/A |
|
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
|
0.032x |
Annual Cash Flow Conversion Efficiency for EDAP TMS S.A. (2006–2025)
The table below shows the annual cash flow conversion efficiency of EDAP TMS S.A. from 2006 to 2025. View FOCL stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.41 Million | $-16.46 Million | -0.848x | -144.36% |
| 2024-12-31 | $42.35 Million | $-14.69 Million | -0.347x | -37.49% |
| 2023-12-31 | $62.88 Million | $-15.87 Million | -0.252x | -507.06% |
| 2022-12-31 | $76.45 Million | $-3.18 Million | -0.042x | -145.03% |
| 2021-12-31 | $56.92 Million | $5.26 Million | 0.092x | +37.06% |
| 2020-12-31 | $33.46 Million | $2.25 Million | 0.067x | -49.46% |
| 2019-12-31 | $31.91 Million | $4.25 Million | 0.133x | +1818.87% |
| 2018-12-31 | $29.73 Million | $206.46K | 0.007x | +106.33% |
| 2017-12-31 | $31.46 Million | $-3.45 Million | -0.110x | -313.56% |
| 2016-12-31 | $26.04 Million | $1.34 Million | 0.051x | -44.85% |
| 2015-12-31 | $15.93 Million | $1.48 Million | 0.093x | +228.02% |
| 2014-12-31 | $18.49 Million | $-1.35 Million | -0.073x | +71.96% |
| 2013-12-31 | $12.79 Million | $-3.32 Million | -0.259x | -1233.87% |
| 2012-12-31 | $10.76 Million | $-209.26K | -0.019x | +78.68% |
| 2011-12-31 | $11.31 Million | $-1.03 Million | -0.091x | +78.44% |
| 2010-12-31 | $11.94 Million | $-5.05 Million | -0.423x | -49.33% |
| 2009-12-31 | $18.05 Million | $-5.11 Million | -0.283x | -0.32% |
| 2008-12-31 | $23.90 Million | $-6.75 Million | -0.282x | -59.14% |
| 2007-12-31 | $21.20 Million | $-3.76 Million | -0.177x | -87.79% |
| 2006-12-31 | $25.45 Million | $-2.41 Million | -0.095x | -- |
About EDAP TMS S.A.
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more